AYALA PHARMACEUTICALS INC (ADXS) Net Income by Year
AYALA PHARMACEUTICALS INC reported a net loss of $48.1M in fiscal year 2023. This represents a decrease of 26.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters AYALA PHARMACEUTICALS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADXS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$48.1M-26.5% | -$38.0M-112.8% | -$17.9M+32.5% | -$26.5M-59.3% | -$16.6M+75.0% | -$66.5M+28.8% | -$93.4M-27.0% | -$73.6M-56.4% | -$47.0M-184.6% | -$16.5M+17.3% | -$20.0M-65.6% | -$12.1M-48.7% | -$8.1M+24.9% | -$10.8M-1263.5% | $929K |
ADXS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More AYALA PHARMACEUTICALS INC financials
Frequently Asked Questions
What was AYALA PHARMACEUTICALS INC's net income in fiscal year 2023?
AYALA PHARMACEUTICALS INC reported a net loss of $48.1M in fiscal year 2023.
How fast is AYALA PHARMACEUTICALS INC's net income growing?
AYALA PHARMACEUTICALS INC (ADXS) net income fell by 26.5% year over year, from -$38.0M to -$48.1M in fiscal year 2023.
How has AYALA PHARMACEUTICALS INC's net income changed over the years?
Across the 15 fiscal years this page covers, AYALA PHARMACEUTICALS INC (ADXS) net income went from $929K in fiscal year 2009 to -$48.1M in fiscal year 2023.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what AYALA PHARMACEUTICALS INC (ADXS) reported on that line in every period on record.